2019
DOI: 10.1016/j.transproceed.2018.10.026
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Impact of a Protocolized Kidney Donor Follow-up System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…Although there was no evidence-based measure to improve renal adaptation, donors who are expected to show poor or insufficient renal adaptation should be more educated for lifestyle modification to reduce risk factors for CKD and actively followed-up by nephrologists. We established a donor clinic in our institution and applied systemized protocols for kidney donors, including post-donation follow-ups since 2013 (23). Poor renal adaptation was less frequent in the donor clinic period compared to the pre-donor clinic period.…”
Section: Discussionmentioning
confidence: 99%
“…Although there was no evidence-based measure to improve renal adaptation, donors who are expected to show poor or insufficient renal adaptation should be more educated for lifestyle modification to reduce risk factors for CKD and actively followed-up by nephrologists. We established a donor clinic in our institution and applied systemized protocols for kidney donors, including post-donation follow-ups since 2013 (23). Poor renal adaptation was less frequent in the donor clinic period compared to the pre-donor clinic period.…”
Section: Discussionmentioning
confidence: 99%
“…Patients should be monitored for the development of cardiovascular diseases, renal impairments, diabetes mellitus, malignancies, and osteoporosis for the best outcomes. Monitoring of dental health, mental health, sexual function, and immunization should also be provided [55].…”
Section: Strategies For Immune Suppression Withdrawal/minimizationmentioning
confidence: 99%
“…Areas that need to be considered, in addition to the graft health relate primarily to minimising the effect of immunosuppressive agents and preventing premature death by focussing on the causes of premature death or co-morbidity (see Table 4 ). The use of a protocolised approach may result in better patient and graft outcomes [ 33 ].…”
Section: Follow-up Of Transplant Recipientsmentioning
confidence: 99%